The CMT Research Foundation (CMTRF), a nonprofit focused solely on delivering treatments and cures for Charcot-Marie-Tooth, today announced it has partnered with DTx Pharma, an RNA medicines company [...]
DTx received a notice of award in September for our first CNS focused grant, targeting the Tau gene/protein implicated in FTLD’s such as PSP as [...]
San Diego, CA. DTx Pharma, an RNA medicines company breaking open new therapeutic areas for oligonucleotide therapeutics, today announced that it will attend the 2019 [...]
Diego, CA. DTx Pharma, an RNA medicines company breaking open new therapeutic areas for oligonucleotide therapeutics, was named by the San Diego Venture Group (SDVG) [...]
San Diego, CA. DTx Pharma, an RNA medicines company breaking open new therapeutic areas for oligonucleotide therapeutics, today announced that it will attend the 2018 [...]
"Jeff is a valuable addition to the DTx Pharma team. He has served as both a scientific and business advisor since the inception of DTx [...]
DTx Pharma, a RNA-based therapeutics company, announced that it has been accepted into the prestigious CONNECT mentoring program. CONNECT is a program whose graduates have [...]
DTx Pharma, a RNA-based therapeutics company, announced that it was one of 3 companies chosen from the JLABs San Diego site to present a 3-minute [...]
DTx Pharma, a RNA-based therapeutics company, announced that Jeff Friedman, Neil Gibson and Timothy Scott joined the scientific advisory board in Q3, 2017 Dr. Friedmans [...]